Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G0BJ
|
||||
Former ID |
DIB008231
|
||||
Drug Name |
VE-821
|
||||
Synonyms |
ATR serine/threonine protein kinase inhibitors (cancer), Oxford University; ATR serine/threonine protein kinase inhibitors (cancer), Vertex Pharmaceuticals
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [542940] | ||
Company |
University of Oxford
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H16N4O3S
|
||||
InChI |
InChI=1S/C18H16N4O3S/c1-26(24,25)14-9-7-12(8-10-14)15-11-20-17(19)16(22-15)18(23)21-13-5-3-2-4-6-13/h2-11H,1H3,(H2,19,20)(H,21,23)
|
||||
InChIKey |
DUIHHZKTCSNTGM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Serine threonine protein kinase ATR | Target Info | Inhibitor | [532880], [532980] | |
PANTHER Pathway | p53 pathway | ||||
p53 pathway feedback loops 2 | |||||
Pathway Interaction Database | Fanconi anemia pathway | ||||
ATR signaling pathway | |||||
Signaling events mediated by TCPTP | |||||
Circadian rhythm pathway | |||||
BARD1 signaling events | |||||
p53 pathway | |||||
Reactome | Meiotic synapsis | ||||
Activation of ATR in response to replication stress | |||||
Regulation of HSF1-mediated heat shock response | |||||
HDR through Single Strand Annealing (SSA) | |||||
Processing of DNA double-strand break ends | |||||
Presynaptic phase of homologous DNA pairing and strand exchange | |||||
G2/M DNA damage checkpoint | |||||
References | |||||
Ref 532880 | Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970. Oncotarget. 2014 Jul 30;5(14):5674-85. | ||||
Ref 532980 | ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses. Cancer Res. 2014 Dec 1;74(23):6968-79. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.